| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |